Avidity Biosciences, Inc. Cash Flow Statement

Cash Flow Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -11.22M-24.72M-44.28M-117.95M-173.94M-211.63M-322.05M
Depreciation and Depletion 0.38M0.35M0.40M0.64M1.40M2.10M2.80M
Share-based Compensation 0.06M0.41M4.31M17.06M27.14M38.22M51.36M
Gains from Investment Securities 1.67M3.79M5.78M1.74M
Non-cash Items 0.56M1.89M
Cash from Operations -9.65M2.49M-37.12M-94.81M-136.27M-119.06M-300.87M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -0.01M0.69M2.75M11.27M21.45M
Amortization of Deferred Charges 0.07M0.07M0.03M
Depreciation & Amortization (CF) 0.38M0.35M0.40M0.64M1.40M2.10M2.80M
Change in Working Capital
Change in Accured Expenses 0.78M1.01M5.75M6.04M18.32M3.15M35.18M
Investing Activities
Capital Expenditures 0.05M0.23M1.09M3.74M2.82M4.23M7.07M
Change in Acquisitions & Divestments 6.58M168.71M335.16M586.40M
Cash from Investing Activities -0.05M-0.23M-7.79M-82.52M-189.96M-130.07M-854.20M
Financing Activities
Other financing activities 0.06M0.02M24.03M17.06M
Debt Issuance and Repayment
Long-Term Debt Issuances 2.99M19.45M
Long-Term Debt Repayments 2.80M4.68M
Change in Capital Stock
Shares Issued 0.16M0.07M274.05M174.68M344.78M60.55M762.16M
Preferred Shares Issued 72.62M2.20M
Misc.
Cash from Financing Activities 5.14M89.23M272.04M176.32M346.17M93.86M1192.36M
Change in Cash -4.56M91.49M227.13M-1.01M19.95M-155.27M37.29M
Free Cash Flow -9.70M2.25M-38.21M-98.55M-139.09M-123.29M-307.94M
Net Cash Flow -4.56M91.49M227.13M-1.01M19.95M-155.27M37.29M